• RVO Overview

    Epidemiology, risk factors, and clinical features of this common cause of r…

    Read Article
  • Treat & Extend Regimen For nAMD

    Read Article
  •  
     
  • DME Disease Education Resource Center
  • Uveitis Resource Center
  • ZEISS OCT Angiography eNewsletter Series
  • AMD Disease Education Resource Center
  • AMD Disease Education Resource Center
  • Articles From This Issue

     

    UP FRONT

    Medical Editor’s Page

    Something For Everyone

    FOUR FAVORITES Retina Today’s choice takeaways from this issue. “After ERM surgery, the macula rarely returns to its original shape, even after months or y…

    News

    Aflibercept Improved DR Severity Score at 6 Months in Patients with NPDR In a phase 3 clinical trial, 58% of patients with nonproliferative diabetic retinopathy (NPDR) …

    BUSINESS MATTERS

    Coding Advisor

    Get Familiar With Payer Audits

    Every payer conducts audits. Given the number of types of audits, the diverse areas they target, and their randomness, the sad reality is that it would be rare for a physician…

     

    Supplements and Inserts

    Supplement

    A Clinical Trial of YAG Vitreolysis By Retinal Specialists

    CME-1 Credit

    AMD in 2017: A Review of Treatment Guidelines and the Role of Early Appropriate Therapy

    Supplement

    THE MULTICENTER UVEITIS STEROID TREATMENT (MUST) TRIAL: A Closer Look at the 7-Year Findings

    CME-1 Credit

    Treatment Paradigms in AMD Management: Assessing Consistent Long-Term Dosing

    NEWS


     

    Researchers Test Stem Cell–Based Retinal Implant for Dry AMD With Encouraging Results

    Physicians and researchers at the USC Roski Eye Institute have collaborated with other California institutions to show that a first-in-kind stem cell-based retinal implant is feasible for us…

    GenSight Biologics Announces Topline Results from Phase 3 Clinical Trial of GS010 in Patients with Leber Hereditary Optic Neuropathy (LHON)

    GenSight Biologics announced that a phase 3 study of GS010 (rAAV2/2-ND4) in patients with Leber hereditary optic neuropathy (LHON) failed to meet its primary endpoint, with sham-treated eyes demonstra…

    Treat-Extend-Stop Protocol for Wet AMD: Long-term Outcomes

    A retrospective chart review was performed for 71 eyes of 67 patients with neovascular age-related macular degeneration (AMD) treated with intravitreal anti-vascular endothelial growth factor (VEGF) i…

    Patients Regain Sight After Being First to Get Retinal Tissue Engineered From Stem Cells

    The first patients to receive a new treatment derived from stem cells for people with wet age-related macular degeneration (AMD) have regained reading vision, according to a report in VisionMonday. Th…

    Contact Info

    Bryn Mawr Communications LLC
    1008 Upper Gulph Road, Suite 200
    Wayne, PA 19087

    Phone: 484-581-1800
    Fax: 484-581-1818

    Karen Roman
    Editor-in-Chief
    484-581-1827
    kroman@bmctoday.com

    Janet Burk
    Publisher
    214-394-3551
    jburk@bmctoday.com

    About Retina Today

    Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.